Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram

Spouse · ALNYLAM PHARMACEUTICALS, INC. · Alnylam Pharmaceuticals, Inc. - Common Stock
Sale (Full)
Disclosed range starting at $1K
Disclosed 29 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $26K 73 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $15K 42 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | Open-market sale | SELL | $44K 118 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 29 | Greenstreet YvonneDirector, Chief Executive Officer | Open-market sale | SELL | $7,822 21 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $28K 76 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $1,117 3 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $7,137 19 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $15K 41 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $2,235 6 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $34K 96 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $56K 155 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $73K 199 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 39 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $5,667 15 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $745 2 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Poulton Jeffrey V.EVP, Chief Financial Officer | Open-market sale | SELL | $32K 87 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 32 | Greenstreet YvonneDirector, Chief Executive Officer | Open-market sale | SELL | $215K 584 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Tanguler TolgaEVP, Chief Commercial Officer | Open-market sale | SELL | $31K 85 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 39 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $80K 220 sh | Jan 14, 2026 traded Jan 12, 2026 | |
| 36 | Garg PushkalEVP Chief R&D | Open-market sale | SELL | $18K 50 sh | Jan 14, 2026 traded Jan 12, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Cory A. Booker reported a sale (full) of Alnylam Pharmaceuticals, Inc. - Common Stock (owner: spouse). Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Recorded votes from the House Clerk and Voteview (Senate). Listed by date; a vote near a trade is not evidence the two are related.